MSc Cancer Therapies at University of Strathclyde

Programme overview

A one-year MSc, unique in the UK, combining cancer biology, drug discovery, formulation and delivery with radiation biology, with emphasis on personalised medicine. It trains students to assess and critically appraise current and emerging anti-cancer therapies from target evaluation to clinical trials.

Department: Strathclyde Institute of Pharmacy & Biomedical Sciences | Duration: 12 months full-time | Intake: September | Study mode: full-time | Location: Glasgow, Scotland, United Kingdom

What you will study

Teaching covers multidisciplinary topics in biology, physical sciences and radiobiology and the principles of developing cancer drugs. Compulsory classes include Essential Skills and Employability for Masters Students (20 credits) and Advanced Techniques in Biomedical Research 1 and 2.

Career pathways

Designed for careers in healthcare, academia, scientific research and industry, including sales, teaching, business and management, technical laboratory posts and scientific writing; graduates are also placed to pursue PhD research.

Official programme page

Application information

Entry requirements

Minimum second-class (2:2) Honours degree or international equivalent in a science or health-related subject. English language (international applicants): IELTS 6.0 overall with no component below 5.5; TOEFL, PTE and other tests accepted. A Pre-Masters Preparation Course is available for international applicants.

Domestic applicants: GBP 13,300 a year (2027/28) Source

International applicants: GBP 34,800 a year (2027/28) Source

Intake: September

Duration: 12 months full-time

Explore more study programmes

Health Sciences